We are delighted to announce that more than 14,000 patients have now been recruited to the Trial Evaluating Cardiovascular Outcomes With Sitagliptin (TECOS) trial.
Investigators from across the globe joined the TECOS management team to celebrate reaching this milestone at the American Diabetes Association (ADA) conference in Philadelphia, USA on Saturday 9th June.
The team organised a reception to bring together TECOS team members who were attending the ADA, to thank and congratulate them for all their hard work in making recruitment to TECOS so successful. The photograph shows TECOS Operations and Executive Committee members together with DCRI and DTU Co-ordinating Centre teams.
Results of this event-driven trial are expected in 2015.
To find out more about the TECOS trial, visit